Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis

被引：0
|
作者：
Che-kai Tsao
Alexander C. Small
Max Kates
Erin L. Moshier
Juan P. Wisnivesky
Benjamin A. Gartrell
Guru Sonpavde
James H. Godbold
Michael A. Palese
Simon J. Hall
William K. Oh
Matthew D. Galsky
机构：
[1] Mount Sinai School of Medicine,Division of Hematology and Medical Oncology, The Tisch Cancer Institute
[2] Mount Sinai School of Medicine,Department of Medicine
[3] Texas Oncology,Department of Medicine, Section of Medical Oncology, Michael E. DeBakey Veterans Affairs Medical Center
[4] Baylor College of Medicine,Department of Urology
[5] Mount Sinai School of Medicine,undefined
来源：
World Journal of Urology | 2013年 / 31卷
关键词：
Cytoreductive nephrectomy; SEER; Targeted therapy; Tyrosine kinase inhibitor; Disparities;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1535 / 1539
页数：4
相关论文
共 50 条
  • [1] Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysis
    Tsao, Che-kai
    Small, Alexander C.
    Kates, Max
    Moshier, Erin L.
    Wisnivesky, Juan P.
    Gartrell, Benjamin A.
    Sonpavde, Guru
    Godbold, James H.
    Palese, Michael A.
    Hall, Simon J.
    Oh, William K.
    Galsky, Matthew D.
    WORLD JOURNAL OF UROLOGY, 2013, 31 (06) : 1535 - 1539
  • [2] The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
    You, Dalsan
    Jeong, In Gab
    Ahn, Jin-Hee
    Lee, Dae Ho
    Lee, Jae-Lyun
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2011, 185 (01): : 54 - 59
  • [3] VALUE OF CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA DURING THE TARGETED THERAPY ERA
    You, Dalsan
    Jeong, In Gab
    Song, Cheryn
    Jung, Han
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    JOURNAL OF UROLOGY, 2010, 183 (04): : E641 - E641
  • [4] Cytoreductive nephrectomy for metastatic renal cell carcinoma: Is it still imperative in the era of targeted therapy?
    Pantuck, Allan J.
    Belldegrun, Arie S.
    Figlin, Robert A.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 693S - 696S
  • [5] Cytoreductive Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma in the Targeted Therapy Era
    Uprety, Dipesh
    Bista, Amir
    Smith, Angela L.
    Vallatharasu, Yazhini
    Marinier, David E.
    ANTICANCER RESEARCH, 2018, 38 (05) : 3013 - 3018
  • [6] Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
    Rodriguez Faba, Oscar
    Brookman-May, Sabine D.
    Linares, Estefania
    Breda, Alberto
    Pisano, Francesca
    Daniel Subiela, Jose
    Sanguedolce, Francesco
    Brausi, Maurizio
    Palou, Joan
    WORLD JOURNAL OF UROLOGY, 2017, 35 (12) : 1807 - 1816
  • [7] The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy EDITORIAL COMMENT
    Akhtar, Naveed H.
    Tagawa, Scott T.
    JOURNAL OF UROLOGY, 2011, 185 (01): : 59 - 59
  • [8] Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
    Oscar Rodriguez Faba
    Sabine D. Brookman-May
    Estefania Linares
    Alberto Breda
    Francesca Pisano
    José Daniel Subiela
    Francesco Sanguedolce
    Maurizio Brausi
    Joan Palou
    World Journal of Urology, 2017, 35 : 1807 - 1816
  • [9] Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma
    Crispen, Paul L.
    Blute, Michael L.
    CURRENT UROLOGY REPORTS, 2012, 13 (01) : 38 - 46
  • [10] Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma
    Paul L. Crispen
    Michael L. Blute
    Current Urology Reports, 2012, 13 : 38 - 46
12345